S
Siddhartha Dutta
Researcher at All India Institute of Medical Sciences
Publications - 64
Citations - 765
Siddhartha Dutta is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 41 publications receiving 166 citations.
Papers
More filters
Journal ArticleDOI
Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review.
Rimple Jeet Kaur,Siddhartha Dutta,Pankaj Bhardwaj,Jaykaran Charan,Sameer Dhingra,Prasenjit Mitra,Kavita Singh,Dharmveer Yadav,Praveen Sharma,Sanjeev Misra +9 more
TL;DR: In this paper, the authors conducted a systematic review of COVID-19 vaccine trials and found that most of the reactions reported were mild to moderate whereas a few with severe intensity.
Journal ArticleDOI
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future.
Brian Godman,Mainul Haque,Salequl Islam,Samiul Iqbal,Umme Laila Urmi,Zubair Mahmood Kamal,Shahriar Ahmed Shuvo,Aminur Rahman,Mustafa Kamal,M. E. Haque,Iffat Jahan,Md. Zakirul Islam,Mohammad Monir Hossain,Munzur-E-Murshid,Santosh Kumar,Jaykaran Charan,Rohan Bhatt,Siddhartha Dutta,Jha Pallavi Abhayanand,Yesh Sharma,Zikria Saleem,Thuy Nguyen Thi Phuong,Hye-Young Kwon,Hye-Young Kwon,Amanj Kurdi,Amanj Kurdi,Janney Wale,Israel Abebrese Sefah +27 more
TL;DR: Encouraging to see increases in utilization of vitamins/immune boosters and PPE across the countries, however, increases in the utilization and prices of antimicrobials is a concern that needs addressing alongside misinformation and any unintended consequences from the pandemic.
Journal ArticleDOI
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database
Rimple Jeet Kaur,Siddhartha Dutta,Jaykaran Charan,Pankaj Bhardwaj,Ankita Tandon,Dharamveer Yadav,Salequl Islam,Mainul Haque +7 more
TL;DR: In this paper, the authors focused on cardiovascular adverse events post-COVID-19 vaccination and aims to determine adverse events with the administered vaccine, and extracted the cardiovascular (CVS) adverse events were extracted for three broad headings (SOCs) - cardiac disorders, vascular disorders, and investigations.
Journal ArticleDOI
Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic Survey.
Jaykaran Charan,Pankaj Bhardwaj,Siddhartha Dutta,Rimple Jeet Kaur,Sunil Kumar Singh Bist,Mohan Dan Detha,Tanuj Kanchan,Dharamveer Yadav,Prasenjit Mitra,Praveen Sharma +9 more
TL;DR: This study included 725 patients from an Isolation center, of which 230 were excluded due to reasons like incorrect phone numbers, no response on phone, or denying consent to participate, and there were no reported acute or severe adverse effects with these products.
Journal ArticleDOI
Favipiravir use in COVID-19: Analysis of suspected adverse drug events reported in the WHO database
Rimple Jeet Kaur,Jaykaran Charan,Siddhartha Dutta,Paras Sharma,Pankaj Bhardwaj,Praveen Sharma,Halyna Lugova,Ambigga Devi S. Krishnapillai,Salequl Islam,Mainul Haque,Sanjeev Misra +10 more
TL;DR: Favipiravir appears to be a relatively safe drug that may explain the improvement in critically ill patients and reduce inflammatory markers, according to a review of adverse drug events reported in the WHO pharmacovigilance database.